TAMPA, Fla. — Jarett Rieger, Esq., MBA, has been named Moffitt Cancer Center’s new vice president and chief innovation officer. Rieger will continue to oversee Moffitt’s Office of Innovation and Industry Alliances, which is focused on commercializing intellectual property and forging industry alliances. He joined Moffitt in 2004 and has served as the manager, director and senior director of this office before being promoted to the new role.

Over the past several years, Rieger has been the lead negotiator on many strategic partnerships with biotechnology and pharmaceutical companies. Recently announced agreements include a multiyear research collaboration with Turnstone Biologics to develop new tumor infiltrating lymphocyte therapies and a 10-year translational science research alliance with Deerfield Management to accelerate the development of new cancer therapeutics. Rieger has been with the Office of Innovation and Industry Alliances since its early days, and with the help of his team has evaluated 930 inventions, secured 241 U.S. patents and executed 238 licenses/intellectual property agreements.

“Jarett has been highly instrumental to the growth and success of Moffitt’s Office of Innovation and Industry Alliances. I have no doubt he will continue to forge and further expand relationships with the biotech industry and advance Moffitt technologies and discoveries in his new leadership role,” said James Mulé, iPh.D., associate center director of Translational Science.

Rieger received his Juris Doctor and Master of Business Administration degrees from Stetson University College of Law. He also holds a Bachelor of Arts in chemistry from Rollins College.  He is board certified in intellectual property law by the Florida Bar and is a Certified Licensing Professional. Additionally, he has been admitted to practice law in Florida and registered to practice before the United States Patent and Trademark Office.   

About Moffitt Cancer Center
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 53 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 7,800 team members, Moffitt has an economic impact in the state of $2.4 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter, Instagram and YouTube.

###